Conformational variability of matrix metalloproteinases: beyond a single 3D structure.

The structures of the catalytic domain of matrix metalloproteinase 12 in the presence of acetohydroxamic acid and N-isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid have been solved by x-ray diffraction in the crystalline state at 1.0 and 1.3-A resolution, respectively, and compared with the previously published x-ray structure at 1.2-A resolution of the adduct with batimastat. The structure of the N-isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid adduct has been solved by NMR in solution. The three x-ray structures and the solution structure are similar but not identical to one another, the differences being sizably higher in the loops. We propose that many of the loops show a dynamical behavior in solution on a variety of time scales. Different conformations of some flexible regions of the protein can be observed as "frozen" in different crystalline environments. The mobility in solution studied by NMR reveals conformational equilibria in accessible time scales, i.e., from 10(-5) s to ms and more. Averaging of some residual dipolar couplings is consistent with further motions down to 10(-9) s. Finally, local thermal motions of each frozen conformation in the crystalline state at 100 K correlate well with local motions on the picosecond time scale. Flexibility/conformational heterogeneity in crucial parts of the catalytic domain is a rule rather than an exception in matrix metalloproteinases, and its extent may be underestimated by inspection of one x-ray structure. Backbone flexibility may play a role in the difficulties encountered in the design of selective inhibitors, whereas it may be a requisite for substrate binding and broad substrate specificity.

[1]  I. Bertini,et al.  Crystal structure of the catalytic domain of human matrix metalloproteinase 10. , 2004, Journal of molecular biology.

[2]  N. Borkakoti Matrix metalloprotease inhibitors: design from structure. , 2004, Biochemical Society transactions.

[3]  I. Bertini,et al.  X-ray structures of binary and ternary enzyme-product-inhibitor complexes of matrix metalloproteinases. , 2003, Angewandte Chemie.

[4]  L Steinman,et al.  Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.

[5]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[6]  R. Powers,et al.  High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR. , 1998, Biochemistry.

[7]  N. Borkakoti Structural studies of matrix metalloproteinases , 2000, Journal of Molecular Medicine.

[8]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[9]  J. Reynolds,et al.  The origin of matrix metalloproteinases and their familial relationships , 1991, FEBS letters.

[10]  Y. Li,et al.  Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor. , 1998, Biochemistry.

[11]  L. Kay,et al.  Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. , 1989, Biochemistry.

[12]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[13]  A. Gearing,et al.  Design and therapeutic application of matrix metalloproteinase inhibitors. , 1999, Chemical reviews.

[14]  L. Kay,et al.  Pulse sequences for removal of the effects of cross correlation between dipolar and chemical-shift anisotropy relaxation mechanisms on the measurement of heteronuclear T1 and T2 values in proteins , 1992 .

[15]  C. Cambillau,et al.  Dynamics of Fusarium solani cutinase investigated through structural comparison among different crystal forms of its variants , 1996, Proteins.

[16]  R. Powers,et al.  Impact of mobility on structure-based drug design for the MMPs. , 2002, Journal of the American Chemical Society.

[17]  Maria Pavlaki,et al.  Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials , 2003, Cancer and Metastasis Reviews.

[18]  W. Stallings,et al.  Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor. , 2002, Biochimica et biophysica acta.

[19]  X. Zhang,et al.  Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1. , 2000, Journal of molecular biology.

[20]  W. Stetler-Stevenson,et al.  Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. , 1996, Seminars in cancer biology.

[21]  R. Powers,et al.  High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor. , 2000, Journal of molecular biology.

[22]  P. Wright,et al.  Suppression of the effects of cross-correlation between dipolar and anisotropic chemical shift relaxation mechanisms in the measurement of spin-spin relaxation rates , 1992 .

[23]  H. Birkedal‐Hansen Proteolytic remodeling of extracellular matrix. , 1995, Current opinion in cell biology.

[24]  M Ikura,et al.  Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. , 1992, Biochemistry.

[25]  D. Hupe,et al.  Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor , 1995, Protein science : a publication of the Protein Society.

[26]  K. Wüthrich,et al.  Torsion angle dynamics for NMR structure calculation with the new program DYANA. , 1997, Journal of molecular biology.

[27]  R. Huber,et al.  Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. , 2001, Journal of molecular biology.

[28]  J. Thornton,et al.  AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.

[29]  J. Prestegard,et al.  Residual dipolar couplings in structure determination of biomolecules. , 2004, Chemical reviews.

[30]  Soumyendu Raha,et al.  Similarity of Binding Sites of Human Matrix Metalloproteinases*[boxs] , 2004, Journal of Biological Chemistry.